{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Peptide Show","title":"Dean Henry: What are the most common peptide mistakes?","html":"","width":"100%","height":180,"duration":1469,"description":"Before you optimize your health, are you actually healthy? \n\nDean Henry has spent more than a decade working with peptides. He has also had enough of everyone calling themselves a biohacker. \n \nAs founder of UAE Peptides and Dn Research, and co-founder of Bioniq Lab, he works with individuals and practitioners navigating peptide protocols across Europe and the Middle East. \nHis interest in health began long before peptides. A knee injury ended his football ambitions before his 16th birthday. Around the same time, he developed difficulty swallowing, with no clear explanation. Years later, he came to understand it as a stress response. \nThat experience still shapes his approach: understand the person before choosing the protocol. \nToday, he sees people comparing stacks before understanding their own health, and questions how much experience some practitioners have with the compounds they recommend. \nDean believes peptides could change medicine. But he wants people to get the basics right first, and a field full of personal success stories to invest in the human trials that can put those stories to the test. \nHe explains:\n\n■ The three mistakes he sees most often when people start using peptides\n■ Why he puts gut health and bloodwork before copying someone else’s stack\n■ How he distinguishes peptide bioregulators from other peptides\n■ Why a medical qualification does not automatically mean peptide expertise\n■ Why he believes the gray market will survive, even as regulated access expands\nChapters\n\n\n\nFurther reading\n\nFDA: Safety concerns and gaps in human data for compounds discussed in the episode, including BPC-157, KPV, injectable GHK-Cu, and TB-500: FDA: Compounding substances with potential safety risks\n\nPubMed: 2026 review of the animal and human evidence for peptides promoted for recovery and performance, including BPC-157, TB-500, and GHK-Cu: Peptide Supplements and Their Therapeutic Applications in Sports Medicine\n\nPubMed: Review co-authored by Professor...","thumbnail_url":"https://img.transistorcdn.com/QcXtaDr9qe6jHT4c0BxQri4VufvdedcvMTMLmbuyqSA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZTg2/YmYyODMzN2NhMDNh/NzMzZGUxMzJhNDFj/YjVmMS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}